The Journal of Immunology · 2019 · 66 citations · 40 references
Life SciencesImmunologyPharmacologyGene ExpressionImmunopathologyInflammationCellular RespirationInflammatory SignalingMetabolic InflammationMitochondrial DysfunctionMitochondrial PhysiologyMitochondrial SignalingCd4 Positive T CellsCd4 T Cell ActivationInterferon-stimulated GenesMetabolic Regulation Of InflammationMitochondrial Respiration ControlMitochondrial Respiration InhibitionMtorc1 SignalingRespiratory Chain Complexes
Abstract In systemic lupus erythematosus, defective clearance of apoptotic debris and activation of innate cells result in a chronically activated type 1 IFN response, which can be measured in PBMCs of most patients. Metformin, a widely used prescription drug for Type 2 diabetes, has a therapeutic effect in several mouse models of lupus through mechanisms involving inhibition of oxidative phosphorylation and a decrease in CD4+ T cell activation. In this study, we report that in CD4+ T cells from human healthy controls and human systemic lupus erythematosus patients, metformin inhibits the transcription of IFN-stimulated genes (ISGs) after IFN-α treatment. Accordingly, metformin inhibited the phosphorylation of pSTAT1 (Y701) and its binding to IFN-stimulated response elements that control ISG expression. These effects were independent of AMPK activation or mTORC1 inhibition but were replicated using inhibitors of the electron transport chain respiratory complexes I, III, and IV. This indicates that mitochondrial respiration is required for ISG expression in CD4+ T cells and provides a novel mechanism by which metformin may exert a therapeutic effect in autoimmune diseases.
40
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton, Samuel E. Weinberg, Robert B. Hamanaka et al. · eLife · 2014 · 1.1K citations · Full text
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Węgrzyn, Ramesh Potla, Yong-Joon Chwae et al. · Science · 2009 · 1K citations · Full text